Back Link
Reader View

Medline (MDLN) Launches AI-Powered Mpower Platform to Enhance Healthcare Supply Chain Resiliency

finance.yahoo.com · Wed, May 6, 2026 at 9:15 PM GMT+8

Medline Inc. (NASDAQ:MDLN) is one of the best young stocks to buy and hold for the next decade. On May 4, Medline officially launched Mpower, a cloud-based, AI-powered digital control tower designed to enhance supply chain resiliency for healthcare providers. Developed in collaboration with Microsoft and informed by feedback from US health systems, the platform integrates predictive analytics and workflow automation into a single dashboard.

This technology allows providers to anticipate potential disruptions, identify at-risk items early, and streamline product substitutions, reducing the operational burden on clinical and supply chain teams. The platform features an integrated AI chat agent that uses Medline Inc.’s (NASDAQ:MDLN) manufacturing and distribution data to offer real-time visibility into inventory and demand forecasts. Mpower is built on Microsoft Azure and integrates with Office 365, ensuring a secure and familiar environment for users with minimal training requirements.

By automating approval workflows and providing proactive optimization tools, the system aims to help organizations navigate global supply chain volatility more effectively. Early data from the initial release involving ten health systems indicates significant performance improvements, including a more than 50% efficiency gain in order substitution workflows. Additionally, organizations utilizing Mpower alongside Medline’s AutoSub program reported a 1-2% increase in unadjusted fill-rates.

Medline Inc. (NASDAQ:MDLN) is a medical instruments & supplies company that serves hospitals, post-acute facilities, and nursing homes through two segments: Medline Brand and Supply Chain Solutions.

While we acknowledge the potential of MDLN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.